These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 28166694)

  • 1. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polidocanol for endovenous microfoam sclerosant therapy.
    Eckmann DM
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of cerebrovascular gas emboli during polidocanol endovenous ultra-low nitrogen microfoam ablation and correlation with magnetic resonance imaging in patients with right-to-left shunt.
    Regan JD; Gibson KD; Rush JE; Shortell CK; Hirsch SA; Wright DD
    J Vasc Surg; 2011 Jan; 53(1):131-7. PubMed ID: 20864303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, placebo-controlled study to evaluate the efficacy and safety of Varithena® (polidocanol endovenous microfoam 1%) for symptomatic, visible varicose veins with saphenofemoral junction incompetence.
    Gibson K; Kabnick L;
    Phlebology; 2017 Apr; 32(3):185-193. PubMed ID: 27013511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of treatment effect with polidocanol endovenous microfoam on varicose vein symptoms and appearance (VANISH-2).
    Todd KL; Wright DI;
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):258-264.e1. PubMed ID: 26992303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfoam sclerotherapy.
    Redondo P; Cabrera J
    Semin Cutan Med Surg; 2005 Dec; 24(4):175-83. PubMed ID: 16387261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive techniques to minimize thrombotic complications following microfoam sclerotherapy of saphenous trunks and tributaries.
    Jimenez JC; Lawrence PF; Woo K; Chun TT; Farley SM; Rigberg DA; Baril DT; Derubertis BG
    J Vasc Surg Venous Lymphat Disord; 2021 Jul; 9(4):904-909. PubMed ID: 33248297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual disturbance following sclerotherapy for varicose veins, reticular veins and telangiectasias: a systematic literature review.
    Willenberg T; Smith PC; Shepherd A; Davies AH
    Phlebology; 2013 Apr; 28(3):123-31. PubMed ID: 23761921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new automated system for the preparation of sclerosant foam: A study of the physical characteristics produced and the device settings required.
    Roche E; Pons R; Roche O; Puig A
    Phlebology; 2020 Oct; 35(9):724-733. PubMed ID: 32635818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous disorders: treatment with sclerosant foam.
    Bergan J; Pascarella L; Mekenas L
    J Cardiovasc Surg (Torino); 2006 Feb; 47(1):9-18. PubMed ID: 16434941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.
    Alòs J; Carreño P; López JA; Estadella B; Serra-Prat M; Marinel-Lo J
    Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):101-7. PubMed ID: 16226901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.